Bonini, M.; Boccabella, C.; Cefaloni, F.; De Corso, E.; Donfrancesco, F.; Schiavi, E.; Richeldi, L.
Small Airways Disease as a Novel Target for Mepolizumab in Asthma—The SASAM Prospective Real-Life Study. J. Clin. Med. 2025, 14, 2928.
https://doi.org/10.3390/jcm14092928
AMA Style
Bonini M, Boccabella C, Cefaloni F, De Corso E, Donfrancesco F, Schiavi E, Richeldi L.
Small Airways Disease as a Novel Target for Mepolizumab in Asthma—The SASAM Prospective Real-Life Study. Journal of Clinical Medicine. 2025; 14(9):2928.
https://doi.org/10.3390/jcm14092928
Chicago/Turabian Style
Bonini, Matteo, Cristina Boccabella, Francesca Cefaloni, Eugenio De Corso, Federico Donfrancesco, Enrico Schiavi, and Luca Richeldi.
2025. "Small Airways Disease as a Novel Target for Mepolizumab in Asthma—The SASAM Prospective Real-Life Study" Journal of Clinical Medicine 14, no. 9: 2928.
https://doi.org/10.3390/jcm14092928
APA Style
Bonini, M., Boccabella, C., Cefaloni, F., De Corso, E., Donfrancesco, F., Schiavi, E., & Richeldi, L.
(2025). Small Airways Disease as a Novel Target for Mepolizumab in Asthma—The SASAM Prospective Real-Life Study. Journal of Clinical Medicine, 14(9), 2928.
https://doi.org/10.3390/jcm14092928
